The protein "Fc fragment of IgG binding protein-like 1," encoded by the gene "23867," is a protein that is presumed to share structural and functional characteristics with known Fc-binding proteins. The Fc region of an immunoglobulin G (IgG) molecule is the tail region that interacts with cell surface receptors-known as Fc receptors-on various immune cells and with proteins of the complement system. This interaction plays a critical role in the immune response, including antibody-dependent cellular cytotoxicity, phagocytosis, and immune complex clearance.The designation "23867" is an identifier that probably corresponds to a specific entry in a genomic or protein database and refers to the gene encoding the Fc fragment of IgG binding protein-like 1. As the name suggests, this protein is thought to resemble other proteins that can bind to the Fc region of IgG antibodies.
While the precise biological functions of Fc fragment of IgG binding protein-like 1 remain to be fully elucidated, it is likely involved in modulating immune responses through its interaction with IgG antibodies. Proteins with Fc-binding capabilities can affect the distribution, function, and half-life of antibodies in the bloodstream and within tissues. They may also play a role in the regulation of immune complex formation and in the prevention of autoimmunity by clearing circulating immune complexes.Investigating the exact role of Fc fragment of IgG binding protein-like 1 within the immune system could further our understanding of how the body regulates immune responses and maintains a balance between defense against pathogens and the prevention of self-reactivity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine is an immunosuppressant that inhibits calcineurin, potentially impacting immune response proteins like FCGBP-L1. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Tacrolimus inhibits calcineurin, affecting T-cell activation and potentially influencing FCGBP-L1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus inhibits mTOR, a key regulator in cell signaling and immune responses, potentially affecting FCGBP-L1. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, impacting lymphocyte proliferation and potentially FCGBP-L1. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Azathioprine is an immunosuppressive drug, potentially impacting proteins like FCGBP-L1 involved in immune responses. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, affecting immune cell proliferation and potentially FCGBP-L1. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine modulates immune activity and could indirectly affect FCGBP-L1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, potentially affecting protein degradation pathways involving FCGBP-L1. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib is a Bruton's tyrosine kinase inhibitor, potentially influencing pathways relevant to FCGBP-L1. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib is a JAK inhibitor, potentially impacting signaling pathways relevant to FCGBP-L1. | ||||||